Literature DB >> 6226285

Alterations in phosphofructokinase isoenzymes during early human development. Establishment of adult organ-specific patterns.

M Davidson, M Collins, J Byrne, S Vora.   

Abstract

Human 6-phosphofructokinase (EC 2.7.1.11) exists in tetrameric isoenzymic forms composed of muscle (M), liver (L) and platelet (P) subunits, which are under separate genetic control. In the adult, the proportion of these subunits in different organs reflects the relative activity of glycolysis versus gluconeogenesis. To elucidate the developmental basis for the observed distribution, we investigated the isoenzymic transitions of phosphofructokinase in human foetuses (12-40 weeks' gestation) by using high-resolution chromatography and monoclonal antibodies. We studied skeletal muscle, heart, liver and brain because these organs show very different glycolytic fluxes and isoenzymic patterns in adult individuals. Our results demonstrate that there is no unique 'foetal' form of phosphofructokinase in humans, but all three loci are variably expressed in all foetal organs during early gestation. As development proceeds, muscle and liver isoenzyme patterns show dramatic changes, with disappearance of P and L subunits in muscle and transient reappearance of M and P subunits in liver; in contrast, phosphofructokinase isoenzymes change little in brain and heart. Most changes occur at mid-gestation and near term, and adult isoenzyme patterns are expressed at birth, indicating that organ differentiation is complete. These studies show that phosphofructokinase undergoes changes of isoenzyme patterns similar to, but not identical with, those of other multilocus isoenzyme systems of glycolysis. The observed changes probably reflect changing patterns of gene expression, with repression of some loci and activation of others.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6226285      PMCID: PMC1152306          DOI: 10.1042/bj2140703

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  23 in total

1.  Multiple forms of phosphofructokinase in developing rabbit and guinea pig tissues.

Authors:  J B de Faria; H A El-Dorry; M Bacila
Journal:  Dev Biol       Date:  1978-08       Impact factor: 3.582

2.  In vivo lability of red cell phosphofructokinase in term infants: the possible molecular basis of the relative phosphofructokinase deficiency in neonatal red cells.

Authors:  S F Travis; J H Garvin
Journal:  Pediatr Res       Date:  1977-11       Impact factor: 3.756

3.  Electrophoretic study of phosphofructokinase isoenzymes from human tissues and tumours of the nervous system.

Authors:  M J Bennett; C B Taylor; W R Timperley
Journal:  Eur J Cancer       Date:  1975-05       Impact factor: 9.162

4.  Enzyme alterations in neonatal heart muscle during development.

Authors:  K M Baldwin; D A Cooke; W G Cheadle
Journal:  J Mol Cell Cardiol       Date:  1977-08       Impact factor: 5.000

5.  Immunologic study of the age-related loss of activity of six enzymes in the red cells from newborn infants and adults--evidence for a fetal type of erythrocyte phosphofructokinase.

Authors:  A Kahn; C Boyer; D Cottreau; J Marie; P Boivin
Journal:  Pediatr Res       Date:  1977-04       Impact factor: 3.756

6.  Isozyme patterns in erythrocytes from human fetuses.

Authors:  S H Chen; J E Anderson; E R Giblett; G Stamatoyannopoulos
Journal:  Am J Hematol       Date:  1977       Impact factor: 10.047

7.  The metabolism of subcutaneous adipose tissue in the immediate postnatal period of human newborns. 2. Developmental changes in the metabolism of 14 C-(U)-D-glucose and in enzyme activities of phosphofructokinase (PFK; EC. 2.7.1.11) and -hydroxyacyl-CoA dehydrogenase (HAD; EC. 1.1.1.35).

Authors:  M Novak; E Monkus; H Wolf; U Stave
Journal:  Pediatr Res       Date:  1972-04       Impact factor: 3.756

8.  Some quantitative biochemical evaluations of developing skeletal muscles in the human foetus.

Authors:  A S Colling-Saltin
Journal:  J Neurol Sci       Date:  1978-12       Impact factor: 3.181

9.  The development of glycolytic and pentose phosphate shunt enzymes in human brain.

Authors:  M J Bennett; W R Timperley; C B Taylor; A S Hill
Journal:  Biol Neonate       Date:  1977

10.  Cell membrane antigen isolation with the staphylococcal protein A-antibody adsorbent.

Authors:  S W Kessler
Journal:  J Immunol       Date:  1976-11       Impact factor: 5.422

View more
  10 in total

1.  Characterization of the enzymatic defect in late-onset muscle phosphofructokinase deficiency. New subtype of glycogen storage disease type VII.

Authors:  S Vora; S DiMauro; D Spear; D Harker; M J Danon
Journal:  J Clin Invest       Date:  1987-11       Impact factor: 14.808

2.  Copy number variation as a genetic basis for heterotaxy and heterotaxy-spectrum congenital heart defects.

Authors:  Jason R Cowan; Muhammad Tariq; Chad Shaw; Mitchell Rao; John W Belmont; Seema R Lalani; Teresa A Smolarek; Stephanie M Ware
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2016-12-19       Impact factor: 6.237

3.  Regional assignment of human liver-type 6-phosphofructokinase to chromosome 21q22.3 by using somatic cell hybrids and a monoclonal anti-L antibody.

Authors:  M Van Keuren; H Drabkin; I Hart; D Harker; D Patterson; S Vora
Journal:  Hum Genet       Date:  1986-09       Impact factor: 4.132

4.  Phosphofructokinase activity in fibroblasts from patients with Alzheimer's disease and age- and sex-matched controls.

Authors:  N R Sims; J P Blass
Journal:  Metab Brain Dis       Date:  1986-03       Impact factor: 3.584

5.  Nonsense mutation in the phosphofructokinase muscle subunit gene associated with retention of intron 10 in one of the isolated transcripts in Ashkenazi Jewish patients with Tarui disease.

Authors:  O Vasconcelos; K Sivakumar; M C Dalakas; M Quezado; J Nagle; M Leon-Monzon; M Dubnick; D C Gajdusek; L G Goldfarb
Journal:  Proc Natl Acad Sci U S A       Date:  1995-10-24       Impact factor: 11.205

Review 6.  Cell culture studies on patients with mitochondrial diseases: molecular defects in pyruvate dehydrogenase.

Authors:  B H Robinson
Journal:  J Bioenerg Biomembr       Date:  1988-06       Impact factor: 2.945

Review 7.  Molecular genetics of human chromosome 21.

Authors:  P C Watkins; R E Tanzi; S V Cheng; J F Gusella
Journal:  J Med Genet       Date:  1987-05       Impact factor: 6.318

8.  Isoenzymes of phosphofructokinase in the rat. Demonstration of the three non-identical subunits by biochemical, immunochemical and kinetic studies.

Authors:  S Vora; R Oskam; G E Staal
Journal:  Biochem J       Date:  1985-07-15       Impact factor: 3.857

9.  Characterization of the enzymatic lesion in inherited phosphofructokinase deficiency in the dog: an animal analogue of human glycogen storage disease type VII.

Authors:  S Vora; U Giger; S Turchen; J W Harvey
Journal:  Proc Natl Acad Sci U S A       Date:  1985-12       Impact factor: 11.205

10.  Analysis of the phosphofructokinase subunits and isoenzymes in human tissues.

Authors:  G A Dunaway; T P Kasten; T Sebo; R Trapp
Journal:  Biochem J       Date:  1988-05-01       Impact factor: 3.857

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.